sarcosine and 3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide

sarcosine has been researched along with 3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kinney, GG; Lindsley, CW; Shipe, WD; Sur, C; Theberge, CR; Williams, DL; Wolkenberg, SE	1

Reviews

1 review(s) available for sarcosine and 3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide

Article	Year
Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Current topics in medicinal chemistry, 2006, Volume: 6, Issue:8 Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Benzamides; Benzimidazoles; Brain; Glycine; Glycine Plasma Membrane Transport Proteins; Humans; Phthalimides; Pyrazoles; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Sarcosine; Schizophrenia; Synaptic Transmission	2006

Article

Year

Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia.

Current topics in medicinal chemistry, 2006, Volume: 6, Issue:8

Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Benzamides; Benzimidazoles; Brain; Glycine; Glycine Plasma Membrane Transport Proteins; Humans; Phthalimides; Pyrazoles; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Sarcosine; Schizophrenia; Synaptic Transmission

2006